• 1
    Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al . Global surveillance for antituberculosis drug resistance:1994–1997. World Health Organization 2 International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med. 1998; 338(23): 16419.
  • 2
    Phthisiology Branch of Chinese Medical Association. The guideline of diagnosis and therapy in pulmonary tuberculosis. Chinese Journal of Tuberculosis and Respiratory Diseases 2002; 24(2): 704.
  • 3
    The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Anti-Tuberculosis drug resistance in the world. Report number 2 Volume. Geneva , 2004
  • 4
    Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis. 1997; 24(Suppl 1): S12130.
  • 5
    He GJ. The importance of molecular biology for multi-drug resistant tuberculosis in new century. Chinese Journal of contagious disease 2001; 19(6): 325.
  • 6
    Blbum of prevenion and cure for tuberculosis in China. Disease Control Bureau of Ministry of Public Health, 2001: 8.
  • 7
    Liu YH, Jiang GL, Zhao LP, Fu YH. The fourth tuberculosis epidemiological random sampling survey in China-the analysis and assessment about the drug resistance of mycobacterium tuberculosis. Chinese Journal of Tuberculosis and Respiratory Diseases 2002; 25(4): 2247.
  • 8
    Angeby KA, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002 Feb; 40(2): 5535.
  • 9
    Panaiotov S, Kantardjiev T. Nitrate reduetase assay for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbio1 2002; 40(10): 388l-2.
  • 10
    Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006; 6(3): 42332.
  • 11
    Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999; 3(7): 56481.
  • 12
    Telenti A. Genetics of drug resistance in tuberculosis. Clin Chest Med 1997; 18(1): 5564.
  • 13
    Tang SJ, Xiao HP. The research in fractional cultivation technology of mycobacterium. Chinese Journal of Tuberculosis and Respiratory Diseases 2000; 23(12): 7624.
  • 14
    Garrigó M, Aragón LM, Alcaide F, Borrell S, Cardeñosa E, Galán JJ, et al . Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2007; 45(6): 176670.
  • 15
    Brunello F, Fontana R. Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs. J Clin Microbiol 2000; 38(2): 8723.
  • 16
    Adjers-Koskela K, Katila ML. Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 2003; 41(3): 12359.
  • 17
    Bemer P, Palicova F, Rüsch-Gerdes S, Drugeon HB, Pfyffer GE. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40(1): 1504.
  • 18
    Qing KQ, Qin J, Zhou XP. Functional assessment of drug sensitivity for BACTEC MGIT 960 in the detection of mycobacterium tuberculosis. Huaxin Medicine 2004; 19(2): 2034.
  • 19
    Zhang YR, Wu XZ, Jing LJ, Chen HP. The comparision of two detection method for mycobacterium tuberculosis. The Journal of Clinical Lung 2003; 8(6): 5612.
  • 20
    Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3(25): 113.
  • 21
    Zamora J, Muriel A, Abraira V: Meta-DiSc for Windows: A Software package for the Meta-analysis of Diagnostic Tests. [http:/
  • 22
    Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21(9): 123756.
  • 23
    Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12(14): 1293316.
  • 24
    Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002; 21(11): 152537.
  • 25
    Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001; 323(7305): 15762.
  • 26
    Pai M, McCulloch M, Enanoria W, Colford JM Jr. Systematic reviews of diagnostic test evaluations: What's behind the scenes? ACP J Club 2004; 141(1): A113.